This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2022 Remove Drug Development Remove HIPAA Remove Patient Experience
article thumbnail

AngelEye Health Announces Series B Funding to Support Company’s Rapid Growth

Healthcare IT Today

NOVEMBER 14, 2022

The Company’s current offering includes four complementary solutions accessible on AngelEye’s comprehensive HIPAA-compliant platform that features advanced communication and engagement resources for NICU clinical teams and the families that they support. In 2022, AngelEye is on pace to deliver nearly 10 million virtual bedside visits.

Life Science 95
Life Science HIPAA Drug Development healthcare technology 95
article thumbnail

Unveiling the Transformative Power: Benefits of AI in Healthcare in 2024

DrKumo Remote Patient Monitoring

FEBRUARY 29, 2024

The Explosive Growth of Generative AI in Healthcare Market by 2032 According to a report from finance.yahoo.com, the global market for generative AI in healthcare, which was estimated at $1,070 million in 2022, is forecasted to surge to around $21,740 million by the year 2032. What are the benefits of AI in drug development?

Mental health 40
Mental health Health Data Drug Development Patient Experience 40
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 82,000+ Insiders by signing up for our newsletter

About
Awards
About
Editions
Awards
Editions
Topics
LinkedIn
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024